ZGNX seems to be helping not hurting as above avg vol & price action yesterday. Reading through the comments overwhelmingly positive to have a safer Hydrocodone product in extended release & APAP free which would eliminate liver toxicity... Even more so some realize the dollar potential of Zohydro Oppenhiemer pegs it around 500 million a year for Zohydro coupled with their migraine drug still growing sales would easily be a $10 to $15 stock. Then throw out there the next Oxycontin & some see $$$$ signs....imo only FDA needs & wants an Acetaminophen free Hydrocodone as they almost eliminated the entire Hydrodone class
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.